Ghana’s Local Vaccine Production Strategy Receives Strong Public Backing Despite Major Awareness Gaps

Ghana’s ambitious journey toward vaccine self-sufficiency has received a significant psychological boost following a comprehensive nationwide survey conducted by the National Vaccine Institute. The study reveals a robust 90% public confidence in vaccines, with an overwhelming 94% of respondents supporting the government's goal to commence local production by 2027. This high level of trust provides a critical foundation for the country's strategic shift to reduce its heavy reliance on international imports and strengthen national health security against future pandemics.

The survey, which engaged 13,905 participants across all 16 regions, highlighted a high degree of faith in healthcare professionals and regulatory bodies. However, it also uncovered a critical disconnect in communication: while 71% of respondents expressed a willingness to use locally manufactured vaccines, a mere 14% were aware of the current active plans to establish these production facilities. Interestingly, the data showed distinct regional disparities, with rural communities exhibiting higher levels of trust and acceptance compared to some urban centers, despite urban populations generally having more immediate access to information.

To bridge these gaps, health experts and officials are calling for a more aggressive communication strategy. Dr. Sodzi Sodzi-Tettey of the National Vaccine Institute emphasized the necessity of a nationwide public education campaign to combat misinformation and clarify the progress of local manufacturing initiatives. Respondents identified potential barriers to uptake, such as vaccine costs and logistical challenges, which must be addressed alongside the technical aspects of manufacturing to ensure the program's long-term sustainability and public buy-in.

This national initiative aligns Ghana with the African Union’s broader vision of achieving 60% local vaccine production across the continent by 2040. By establishing its own manufacturing hub, Ghana aims to protect its population from global supply chain disruptions while fostering economic growth within the pharmaceutical sector. The survey findings serve as a vital roadmap for health authorities, suggesting that while the public appetite for 'Made in Ghana' medical products is strong, success will ultimately hinge on transparent communication, robust infrastructure, and the elimination of socio-economic barriers to access.